Skip to main navigation Skip to search Skip to main content

Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist inhibits collagen synthesis in human hypertrophic scar fibroblasts by targeting Smad3 via miR-145

  • Hua Yu Zhu
  • , Chao Li
  • , Zhao Zheng
  • , Qin Zhou
  • , Hao Guan
  • , Lin Lin Su
  • , Jun Tao Han
  • , Xiong Xiang Zhu
  • , Shu Yue Wang
  • , Jun Li
  • , Da Hai Hu
  • Xijing Hospital

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Abstract

The transcription factor peroxisome proliferator-activated receptor-γ (PPAR-γ) functions to regulate cell differentiation and lipid metabolism. Recently, its agonist has been documented to regulate extracellular matrix production in human dermal fibroblasts. This study explored the underlying molecular mechanisms and gene interactions in hypertrophic scar fibroblasts (HSFBs) in vitro. HSFBs were cultured and treated with or without PPAR-γ agonist or antagonist for gene expression. Bioinformatical analysis predicted that miR-145 could target Smad3 expression. Luciferase assay was used to confirm such an interaction. The data showed that PPAR-γ agonist troglitazone suppressed expression of Smad3 and Col1 in HSFBs. PPAR-γ agonist induced miR-145 at the gene transcriptional level, which in turn inhibited Smad3 expression and Col1 level in HSFBs. Furthermore, ELISA data showed that Col1 level in HSFBs was controlled by a feedback regulation mechanism involved in PPAR-γ agonist and antagonist-regulated expression of miR-145 and Smad3 in HSFBs. These findings indicate that PPAR-γ-miR-145-Smad3 axis plays a role in regulation of collagen synthesis in HSFBs.

Original languageEnglish
Pages (from-to)49-53
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume459
Issue number1
DOIs
StatePublished - 30 May 2015
Externally publishedYes

Keywords

  • Col1
  • Fibrosis
  • Hypertrophic scar fibroblasts
  • PPAR-γ agonist
  • Smad3
  • miR-145

Fingerprint

Dive into the research topics of 'Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist inhibits collagen synthesis in human hypertrophic scar fibroblasts by targeting Smad3 via miR-145'. Together they form a unique fingerprint.

Cite this